Disease ⇒ Urinary stone disease {40000161}
Type: | Disease |
---|---|
Parent: | [ ] |
Definition: | Urinary stone disease |
Initialisation date: | 2020-09-06 |
---|---|
Other Terms: | Urinary Calculi, Nephrolithiasis, Stones, Urolithiasis |
MedDra ID: | [ ] |
---|---|
MedDra Level: | [ ] |
ICD: | [ ] |
Zone: | [ ] |
Mechanism: | [ ] |
Notes:
[ ]
Shared Reference Notes
- [1.1]
- Lactobacillus may inhibit stone growth. However, our multi-omics integration strongly points to three unknown metabolites. - The bacterium Oxalobacter formigenes uses oxalate as a carbon and energy source for growth, is negatively associated with both USD and urinary oxalate, is sensitive to common antibiotics, and can reduce urinary oxalate when administered orally as a probiotic, all of which implicates loss of function dysbiosis associated with this species and calcium oxalate stone formation. - [1.2] [#Antibiotic Therapy]
- antibiotics cause a rapid loss of gut microbial #oxalate metabolism, and while disturbed bacteria can partially recover over time, the ability to metabolize #oxalate does not. - This results in the accumulation of oxalates in the body and increases the risk of kidney stones. - [1.3] [#Kidney stone]
References Notes
[ ]